Did GlaxoSmithKline's 1Q17 Earnings Meet
Did GlaxoSmithKline's 1Q17 Earnings Meet Expectations?Market RealistAs discussed earlier, GlaxoSmithKline's (GSK) pharmaceuticals segment revenues saw growth of 17% to ~4.2 billion pounds in 1Q17 as compared to 1Q16. This includes an operational growth of 4% and a positive impact from foreign exchange. The growth ...and more »
Posted on 28 April 2017 | 1:52 pm
Anthera Pharmaceuticals Announces 1-for-8
Anthera Pharmaceuticals Announces 1-for-8 Reverse Split of StockYahoo FinanceHAYWARD, Calif., April 28, 2017 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (ANTH) announced today that it has filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation to effect a 1-for-8 reverse stock split of ...and more »
Posted on 28 April 2017 | 1:08 pm
Regeneron Pharmaceuticals Breaks Above
StockNewsJournalRegeneron Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for REGNNasdaqIn trading on Friday, shares of Regeneron Pharmaceuticals, Inc. (Symbol: REGN) crossed above their 200 day moving average of $383.77, changing hands as high as $385.43 per share. Regeneron Pharmaceuticals, Inc. shares are currently trading up about ...Lookout for Price Target? Regeneron Pharmaceuticals, Inc. (REGN), Fifth Third Bancorp (FITB)StockNewsJournalRegeneron Pharmaceuticals Inc (REGN) Shares Sold by Gateway Investment Advisers LLCThe Cerbat Gemall 91 news articles »
Posted on 28 April 2017 | 9:30 am
Teva Pharmaceutical Is Looking to Deal, and
Motley FoolTeva Pharmaceutical Is Looking to Deal, and That's a Good ThingMotley FoolThe tables have turned pretty quickly for Israeli-based branded- and generic-drug developer Teva Pharmaceutical Industries (NYSE:TEVA). In July 2015, shares of the company were trading north of $72, an all-time high. Today, Teva's stock is struggling ...Eagle Pharmaceuticals,Inc. (NYSE:TEVA) Files An 8-K Regulation FD DisclosureMarket Exclusiveall 46 news articles »
Posted on 28 April 2017 | 7:21 am
Exclusive: Ritter Pharmaceuticals CEO Talks
BenzingaExclusive: Ritter Pharmaceuticals CEO Talks Stock Scare, Indication NicheBenzingaAndrew Ritter, co-founder and president of Ritter Pharmaceuticals Inc (NASDAQ: RTTR), has found his niche. There are currently no FDA-approved treatments or reliable over-the-counter remedies for the 40 million Americans suffering lactose intolerance, ...Jones Energy (JONE) Reaches $2.03 52-Week Low; Ritter Pharmaceuticals (RTTR) Shorts Down By 12.06%HuronReportall 10 news articles »
Posted on 28 April 2017 | 7:09 am
NovaBay Pharmaceuticals to Offer Educational
At the April 19 workshop and dinner, nationally prominent eye experts will describe improvements in lid hygiene regimens made possible by NovaBay's Avenova lid cleanser EMERYVILLE, CA / ACCESSWIRE / April ...
Posted on 10 April 2015 | 9:25 am
Adamas Pharmaceuticals Receives Orphan Drug
EMERYVILLE, Calif. -- Adamas Pharmaceuticals, Inc. today announced that the Food and Drug Administration (FDA) has granted orphan drug status to ADS-5102 for the treatment of levodopa-induced dyskinesia ...
Posted on 10 April 2015 | 5:30 am
Reata Pharmaceuticals Receives Orphan Drug
Reata Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of breakthrough medicines for difficult-to-treat diseases, today announced that the FDA Office of Orphan Products Development ...
Posted on 10 April 2015 | 4:30 am
Tokai Pharmaceuticals to Present at Upcoming
Tokai Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally-driven diseases
Posted on 10 April 2015 | 4:00 am
Adamas Pharmaceuticals to Present at 2015
EMERYVILLE, Calif. -- Adamas Pharmaceuticals, Inc. today announced that Gregory T. Went, PhD., Chief Executive Officer, will present at the 2015 Needham Healthcare Conference in New York on Tuesday, April ...
Posted on 9 April 2015 | 1:01 pm
Amgen wins approval for second biotech
Sanofi and partner Regeneron Pharmaceuticals Inc. won FDA approval for that drug last month. Analysts estimate between 8 million to 10 million patients are covered under the FDA-approved labeling for the drugs. But some experts worry the drugs could ...
Posted on 27 August 2015 | 10:18 pm
Singapore manufacturing falls 6.1%
SINGAPORE: The Republic's industrial production fell year-on-year for the sixth straight month in July, hurt by lower output of electronics, pharmaceuticals and rigs, EDB reported on Wednesday (Aug 26). Production in the electronics cluster fell 5.8 per ...
Posted on 27 August 2015 | 9:52 pm
New Data on Actelion Pulmonary Arterial
Actelion Pharmaceuticals Ltd recently announced in a press release that new data on its investigational drug selexipag (Uptravi®) and the approved macitentan (Opsumit®) for pulmonary arterial hypertension will be presented at the upcoming European ...
Posted on 27 August 2015 | 9:45 pm
Teva Pharmaceutical Industries Ltd (ADR) Not
Teva has successfully switched patients to the 3x/week (40mg) from the once/daily (20mg)…” Teva continues to face generic competition on its once/daily (20mg) regimen from Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) and Sandoz, the generic drug unit of ...
Posted on 27 August 2015 | 9:12 pm
ACADIA Pharmaceuticals Stock Rating
ACADIA Pharmaceuticals (NASDAQ:ACAD)‘s stock had its “outperform” rating reaffirmed by Cowen and Company in a note issued to investors on Friday, MarketBeat reports. They currently have a $50.00 price target on the biopharmaceutical company’s stock.
Posted on 27 August 2015 | 8:43 pm
NJ drug company execs charged with insider
Executives at two leading drug companies were among six people arrested Monday and charged with insider trading in what federal prosecutors said was a five-year-long scheme that netted more than $1 million.
Posted on 19 November 2012 | 10:46 am
AG: J&J must pay $52M in Pa. drug pricing
Johnson & Johnson must pay $52 million in damages and penalties after a Pennsylvania judge found the pharmaceutical company falsely reported the prices of its drugs.
Posted on 17 December 2010 | 3:19 pm
Pfizer will buy King Pharmaceuticals for
Pfizer Inc. said Tuesday it will buy a company specializing in pain drugs in a $3.6 billion deal meant to shore up the portfolio of the world's largest drug company.
Posted on 11 October 2010 | 5:12 pm
Endo Pharma paying $1.2 billion for
Drug developer Endo Pharmaceuticals Holdings Inc. said Tuesday it is buying Qualitest Pharmaceuticals for $1.2 billion in a move to diversify its business and strengthen its position in the generic and pain drug markets.
Posted on 28 September 2010 | 3:22 am
Teva plans to appeal lawsuit verdict
Drugmaker Teva Pharmaceutical Industries Ltd. plans to appeal a $356 million Las Vegas district court verdict awarded to a plaintiff who says he contracted hepatitis C when one of Teva's drug vials was used by more than one patient.
Posted on 8 May 2010 | 8:56 am